| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstract list
|
|
|
2017
|
36 |
S1 |
p. S83-S85
3 p.
|
artikel
|
| 2 |
Abstract Presenters
|
|
|
2017
|
36 |
S1 |
p. S15-S16
2 p.
|
artikel
|
| 3 |
Adjuvant Therapies for Breast Cancer Improve Cure Rates but Appear to Shorten Post-Metastatic Survival
|
Harbeck, Nadia
|
|
2017
|
36 |
S1 |
p. S74-
1 p.
|
artikel
|
| 4 |
Advanced Breast Cancer in Malesia
|
Nair, Viji
|
|
2017
|
36 |
S1 |
p. S37-
1 p.
|
artikel
|
| 5 |
Advanced Breast Cancer in Young Women: Outcome of a Portuguese Hospital
|
da Silva Dias, David
|
|
2017
|
36 |
S1 |
p. S56-S57
2 p.
|
artikel
|
| 6 |
Advanced Breast Cancer Prevalence and Related Personal Factors
|
Ninashvili, Nanuli
|
|
2017
|
36 |
S1 |
p. S74-S75
2 p.
|
artikel
|
| 7 |
Advanced Stage Breast Cancer Lifestyle and Exercise (ABLE) Feasibility Study: Preliminary Results
|
Delrieu, Lidia
|
|
2017
|
36 |
S1 |
p. S66-S67
2 p.
|
artikel
|
| 8 |
Adverse Events (AE) of Targeted Agents Added to Endocrine Therapy in Patients with Hormone Receptor-positive Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
|
Lambertini, Matteo
|
|
2017
|
36 |
S1 |
p. S43-S44
2 p.
|
artikel
|
| 9 |
All Oral Combination of Vinorelbine and Capecitabile as a First Line Treatment in Patients (PTS) with Metastatic Breast Cancer (MBC)
|
Shehata, Samir
|
|
2017
|
36 |
S1 |
p. S53-
1 p.
|
artikel
|
| 10 |
Analysis of the Gaps on Metastatic Breast Cancer Global Policies and Advocacy Efforts to Support Policy Development across the Patient Journey
|
Thrift-Perry, Maia
|
|
2017
|
36 |
S1 |
p. S31-
1 p.
|
artikel
|
| 11 |
An Investigation into the Psycho-Social Benefits of Women Attending UK Charity Breast Cancer Care’s ‘Living with Secondary Breast Cancer’ Service: A Group Based Psycho-Educational Intervention
|
Priestley, Catherine
|
|
2017
|
36 |
S1 |
p. S73-S74
2 p.
|
artikel
|
| 12 |
A Novel and Innovative ‘Non-Tunneling’ Technique of Port Insertion for Chemotherapy Infusion in Advance Breast Cancer Patients: A Single Center Study in 130 Patients
|
Deshpande, Abhinav
|
|
2017
|
36 |
S1 |
p. S64-
1 p.
|
artikel
|
| 13 |
A Phase II Study of Metronomic Daily Oral Vinorelbine as First-Line Chemotherapy in Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer Resistant to Endocrine Therapy: Vinometro
|
Thomssen, Christoph
|
|
2017
|
36 |
S1 |
p. S51-
1 p.
|
artikel
|
| 14 |
Are PALB2 Mutation Carriers at a Higher Risk of Death from Breast Cancer?
|
Kashyap, Aniruddh
|
|
2017
|
36 |
S1 |
p. S40-
1 p.
|
artikel
|
| 15 |
A Retrospective Cohort Study to Investigate Association between Preferences for Future Care and Period of Final Chemotherapy Administration before End-of-Life
|
Yamamoto, Sena
|
|
2017
|
36 |
S1 |
p. S66-
1 p.
|
artikel
|
| 16 |
A Study of Nursing Provision and Models of Care for People Diagnosed and Living with Metastatic Breast Cancer in Britain: What are the Implications for the Practice? and What Role Does Patient Advocacy Play?
|
Priestley, Catherine
|
|
2017
|
36 |
S1 |
p. S33-
1 p.
|
artikel
|
| 17 |
Author index
|
|
|
2017
|
36 |
S1 |
p. S79-S82
4 p.
|
artikel
|
| 18 |
Award
|
|
|
2017
|
36 |
S1 |
p. S6-S7
2 p.
|
artikel
|
| 19 |
A Woman with Von Recklinghausen and a Resectable Brain Metastasis HER2 Positive
|
Andreadou, Anna
|
|
2017
|
36 |
S1 |
p. S61-
1 p.
|
artikel
|
| 20 |
BC III and IV Treatment in Brazil: Differences between Public Health, Supplementary Health and Iternational Protocol Recommendations
|
Caleffi, Maira
|
|
2017
|
36 |
S1 |
p. S34-
1 p.
|
artikel
|
| 21 |
Benefit in Overall Survival of Loco-Regional Control among Patients with Metastatic Breast Cancer
|
Nieto-Coronel, Maria Tereza
|
|
2017
|
36 |
S1 |
p. S58-
1 p.
|
artikel
|
| 22 |
Brain Mestastasis at Diagnosis from Breast Cancer, Clinical Pathological Features and Survival
|
Munoz-Moñtano, Wendy
|
|
2017
|
36 |
S1 |
p. S57-
1 p.
|
artikel
|
| 23 |
Breast Cancer Knowledge and Quality of Life Among Participants of a Breast Cancer Support Group in Rural Ruwanda
|
Ndaysaba, Thomas Albert
|
|
2017
|
36 |
S1 |
p. S36-
1 p.
|
artikel
|
| 24 |
Breast Cancer Liver Metastases: When to Operate
|
Devezas, Vítor
|
|
2017
|
36 |
S1 |
p. S62-S63
2 p.
|
artikel
|
| 25 |
Breast Cancer Patient Advocacy Programme
|
|
|
2017
|
36 |
S1 |
p. S8-
1 p.
|
artikel
|
| 26 |
Breast Reconstruction is Possible in Locally Advanced and Inflammatory Breast Cancer
|
Venter, Marisse
|
|
2017
|
36 |
S1 |
p. S65-S66
2 p.
|
artikel
|
| 27 |
Building A Voice for Metastatic Breast Cancer Patients through a Multi-Year Awareness Campaign
|
Faucette, Craig
|
|
2017
|
36 |
S1 |
p. S36-
1 p.
|
artikel
|
| 28 |
Cancer Associated Fibroblasts Display Phenotypic and Functional Features that Resemble Circulating Fibrocytes with Constitute a Nove Subset of MDSCs
|
Gunaydin, Gurcan
|
|
2017
|
36 |
S1 |
p. S43-
1 p.
|
artikel
|
| 29 |
Capecitabine and Vinorelbine Combination More Effective as the First Line Treatment of Advanced ER Positive Breast Cancer
|
Kassem, Loay
|
|
2017
|
36 |
S1 |
p. S52-
1 p.
|
artikel
|
| 30 |
Capecitabine in the Treatment of Metastatic Breast Cancer: Single-Institution Retrospective Analysis
|
Gaballah, Ahmed
|
|
2017
|
36 |
S1 |
p. S59-
1 p.
|
artikel
|
| 31 |
Characteristics of the Metastatic Breast Cancer Population with PIK3CA Mutation in the Randomized Phase II Study SAFIR02 Breast (UCBG-0105/1304)
|
Lefeuvre-Plesse, Claudia
|
|
2017
|
36 |
S1 |
p. S44-
1 p.
|
artikel
|
| 32 |
Chest Wall Disease: The Clinical Continuum between Inflammatory and Lymphangitic Breast Cancer
|
Curigliano, Giuseppe
|
|
2017
|
36 |
S1 |
p. S25-
1 p.
|
artikel
|
| 33 |
Circualting Tumour DNA Analysis in Breast Cancer
|
Turner, Nicholas C.
|
|
2017
|
36 |
S1 |
p. S26-
1 p.
|
artikel
|
| 34 |
Clinical Study to Improve Patient-HCP Communication & Engagement for Newly Diagnosed Metastatic Breast Cancer Patients
|
Beaumont, Corrine Ellsworth
|
|
2017
|
36 |
S1 |
p. S38-
1 p.
|
artikel
|
| 35 |
Clinicopathological Characteristics, Prognosis and Issues in Young Women (<40 Years Old) with Recurrent or Metastatic Breast Cancer
|
Ushimado, Kaori
|
|
2017
|
36 |
S1 |
p. S75-S76
2 p.
|
artikel
|
| 36 |
Clinicopathological Factors and Prognosis in Elderly Recurrent Breast Cancer Patients Older than 75-Years-Old
|
Ishida, Mayumi
|
|
2017
|
36 |
S1 |
p. S76-
1 p.
|
artikel
|
| 37 |
Coping with Metastatic Breast Cancer: The Patients’ Perspective in a Brazilian Cancer Center
|
Caleffi, Maira
|
|
2017
|
36 |
S1 |
p. S38-
1 p.
|
artikel
|
| 38 |
Creating a Novel Drug Navigation Tool for Metastatic Breast Cancer Drugs in Canada
|
Faucette, Craig
|
|
2017
|
36 |
S1 |
p. S36-S37
2 p.
|
artikel
|
| 39 |
Disclosure of Conflict of Interest
|
|
|
2017
|
36 |
S1 |
p. S77-S78
2 p.
|
artikel
|
| 40 |
Discordance of Hormone Receptor and Human Epidermal Growth Factor Receptor2 as a Prognostic Factor of Survival between Primary Breast Cancer and Recurrent Breast Cancer
|
Kim, Euitae
|
|
2017
|
36 |
S1 |
p. S64-
1 p.
|
artikel
|
| 41 |
Does Eribulin Have an Effect on Anti-Tumor Activities of the Subsequent Regimen Used in Metastatic Breast Cancer
|
Choi, Jihye
|
|
2017
|
36 |
S1 |
p. S60-
1 p.
|
artikel
|
| 42 |
Does Oligo-Metastatic Breast Cancer Warrant a Multidisciplinary Approach with Curative Intent?
|
Steenbruggen, Tessa
|
|
2017
|
36 |
S1 |
p. S60-
1 p.
|
artikel
|
| 43 |
Does the Choice of First-Line Chemotherapy Influence the Outcome of ER+HER2: Metastatic Breast Cancer?
|
Watanabe, Junichiro
|
|
2017
|
36 |
S1 |
p. S61-
1 p.
|
artikel
|
| 44 |
Doxycyclin Inhibits Breast Cancer Stem Cells under Hypoxic Conditions
|
Akhunzianov, Almaz
|
|
2017
|
36 |
S1 |
p. S42-
1 p.
|
artikel
|
| 45 |
Editorial Board
|
|
|
2017
|
36 |
S1 |
p. ii-
1 p.
|
artikel
|
| 46 |
Educate-Empower-Advocate: A New Model for Advocacy and Creating Change for Women with Metastatic Breast Cancer
|
DeCoteau, M.J.
|
|
2017
|
36 |
S1 |
p. S33-S34
2 p.
|
artikel
|
| 47 |
Effect of Exercise on Cardiovascular Fitness and Quality of Life Outcomes in Advanced Breast Cancer Patients
|
Oliveira, Eduardo
|
|
2017
|
36 |
S1 |
p. S71-S72
2 p.
|
artikel
|
| 48 |
Effects of Pan-Active BCL-2 Protein Family Antagonist Sabutoclax on Overcoming Drug Resistance and Eliminating Cancer Stem Cells in Human Breast Cancer Cells
|
Zhang, Jin
|
|
2017
|
36 |
S1 |
p. S40-
1 p.
|
artikel
|
| 49 |
Efficacy and Safety of Eribulin in Combination with Trastuzimab in HER2-Positive Metastatic Breast Cancer Patients: Real Life Experience
|
Kovalenko, Elena Igorevna
|
|
2017
|
36 |
S1 |
p. S54-
1 p.
|
artikel
|
| 50 |
Efficacy and Safety of Eribulin in Patients with HER2-Negative Metastatic Breast Cancer: Real Life Experience
|
Zhilyaeva, Larisa
|
|
2017
|
36 |
S1 |
p. S53-S54
2 p.
|
artikel
|
| 51 |
Efficacy and Safety of Eribulin in Patients with Triple Negative Metastatic Breast Cancer: Real Life Experience
|
Valentinova, Ludmila Manzyuk
|
|
2017
|
36 |
S1 |
p. S57-S58
2 p.
|
artikel
|
| 52 |
Efficacyand Safety of Palbociclib (PAL) PUS Fulvestrant (F) by Geographic Region in Women with Endocrine-Resistant Hormone Receptor-Positive (HR+), Human Epiderman Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer (ABC) from Paloma-3
|
Harbeck, Nadia
|
|
2017
|
36 |
S1 |
p. S47-
1 p.
|
artikel
|
| 53 |
Efficacy and Safety of Platinum and Metronomic Cyclophosphamide in Triple Negative Breast Cancer
|
Viale, Giulia
|
|
2017
|
36 |
S1 |
p. S47-
1 p.
|
artikel
|
| 54 |
Efficacy and Toxicity of Eribulin in Real-Life Non-Selected Advanced Breast Cancer Patients
|
Brems-Eskildsen, Anne Sofie
|
|
2017
|
36 |
S1 |
p. S52-S53
2 p.
|
artikel
|
| 55 |
Efficacy of Capecitabile Monotherapy as Treatment for Real Life Patients with HER2-Negative Mestastatic Breast Cancer
|
Sharma, Maja Bendtsen
|
|
2017
|
36 |
S1 |
p. S53-
1 p.
|
artikel
|
| 56 |
Efficacy of First Line Regimens in Metastatic Breast Cancer Patients. Real World Evidence from Instituto Nacional de Cancerologia, Mexico City
|
Nieto-Coronel, Maria Tereza
|
|
2017
|
36 |
S1 |
p. S50-
1 p.
|
artikel
|
| 57 |
Ehealth: Friend or FOE
|
Schinköthe, Timo
|
|
2017
|
36 |
S1 |
p. S29-
1 p.
|
artikel
|
| 58 |
Electrochemoterapy (ECT) Treatment In-Patient with Bone Foot Metastasis from Breast: A Case Report
|
Screpis, Daniele
|
|
2017
|
36 |
S1 |
p. S64-S65
2 p.
|
artikel
|
| 59 |
End of Life (EOL) Communication – The Healthcare Provider Perspective
|
Fallowfield, Lesley
|
|
2017
|
36 |
S1 |
p. S27-S28
2 p.
|
artikel
|
| 60 |
ERBB2 Amplification Level and PTPN2 Gain as Potential Prognostic Factors in Metastatic HER2-Positive Breast Cancer Treated with Trastuzumab
|
Ellegard, Sander
|
|
2017
|
36 |
S1 |
p. S46-
1 p.
|
artikel
|
| 61 |
Evaluation of Health-Related Quality of Life via the Computer-Based Health Evaluation System (CHES) for Japanese Metastatic Breast Cancer Patients: A Singlecenter Pilot Study
|
Kikawa, Yuichiro
|
|
2017
|
36 |
S1 |
p. S70-S71
2 p.
|
artikel
|
| 62 |
Evaluation of Pertuzumab Treatment for Metastatic Breast Cancer in a Retrospective Single Institution Study
|
Yamamoto, Mitsugu
|
|
2017
|
36 |
S1 |
p. S55-
1 p.
|
artikel
|
| 63 |
Experience of Advanced Breast Cancer Patients in the Australian Health System and their Expectations of Future Treatments and Care
|
Holliday, Catherine
|
|
2017
|
36 |
S1 |
p. S38-S39
2 p.
|
artikel
|
| 64 |
Exploring Support Networks and Quality of Life of Metastatic Breast Cancer Patient in Nigeria and Turkey
|
Chikeruba, Runcie
|
|
2017
|
36 |
S1 |
p. S71-
1 p.
|
artikel
|
| 65 |
First-Line Ribociclib Plus Letrozole for Postmenopausal Women with HR+, HER2-ABC: Manaleesa-2 Safety Results
|
Janni, Wolfgang
|
|
2017
|
36 |
S1 |
p. S44-S45
2 p.
|
artikel
|
| 66 |
First-Line Treatment Modality for Metastatic Breast Cancer: A Single-Institution Outcome Analysis by Metastatic Site and Molecular Type
|
Burcombe, Russell
|
|
2017
|
36 |
S1 |
p. S72-
1 p.
|
artikel
|
| 67 |
Five Years Overall Survival of Locally Advanced Triple-Negative Breast Cancer in West Sumatera, Indonesia
|
Khambri, Daan
|
|
2017
|
36 |
S1 |
p. S65-
1 p.
|
artikel
|
| 68 |
Fostering Innovation in Advocacy for Metastatic Breast Cancer
|
Teahon, Marina
|
|
2017
|
36 |
S1 |
p. S32-
1 p.
|
artikel
|
| 69 |
Gastrointestinal and Other Selected Adverse Effects of Cyclin-Dependent Kinase 4 and 6 Inhibitors in Breast Cancer Patients: A Systematic Review and Meta-Analysis
|
Shohdy, Kyrillus
|
|
2017
|
36 |
S1 |
p. S58-
1 p.
|
artikel
|
| 70 |
G-CSF and G-CSF Biosimilars: A Meta-Analysis of Randomized Clinical Trials in Breast Cancer Patients Undergoing Myelosuppressive Chemotherapy
|
Curigliano, Giuseppe
|
|
2017
|
36 |
S1 |
p. S69-
1 p.
|
artikel
|
| 71 |
General Information
|
|
|
2017
|
36 |
S1 |
p. S2-S3
2 p.
|
artikel
|
| 72 |
Gisel Study Group Proposal: A Phase II Randomized Clinical Trial in Breast Cancer Patients with Skin Metastases Treated with or without Electrochemotherapy (ECT) during the First Line of Treatment
|
Agresti, Roberto
|
|
2017
|
36 |
S1 |
p. S63-
1 p.
|
artikel
|
| 73 |
Global Access to Radiotherapy
|
Gospodarowicz, Mary K.
|
|
2017
|
36 |
S1 |
p. S28-
1 p.
|
artikel
|
| 74 |
Hard Choices, Last Days, Final Gifts: Patient and Family Voices at the End of Life
|
Mayer, Musa
|
|
2017
|
36 |
S1 |
p. S28-
1 p.
|
artikel
|
| 75 |
Harvesting Population Data to Aid Treatment Decisions in Heavily Pre-Treated Advanced Breast Cancer
|
Alford, Sharon Hensley
|
|
2017
|
36 |
S1 |
p. S76-
1 p.
|
artikel
|
| 76 |
Herceptin Alone in Comparison with Herceptin Combined Evorilimus in Asian Patients with HER2+ Breast Cancer
|
Djuraev, Farrukh
|
|
2017
|
36 |
S1 |
p. S45-S46
2 p.
|
artikel
|
| 77 |
Her2 Resistance Factors: Implications in Her2 Positive ABC
|
Gelmon, Karen
|
|
2017
|
36 |
S1 |
p. S20-S21
2 p.
|
artikel
|
| 78 |
High Patronage, Endorsement and Auspices
|
|
|
2017
|
36 |
S1 |
p. S4-
1 p.
|
artikel
|
| 79 |
Homestatic Correlations in Patients with Breast and Ovarian Cancer
|
Beleva, Elina
|
|
2017
|
36 |
S1 |
p. S71-
1 p.
|
artikel
|
| 80 |
IL-2 Mediated Improvement of Cell Antitumor Activity in Advanced Breast Cancer Patients
|
Radenkovic, Sandra
|
|
2017
|
36 |
S1 |
p. S41-
1 p.
|
artikel
|
| 81 |
Impact of Disease Progression Status on time to Deterioration of Patient Reported Health Related Quality of Life in Forst Line ER+ HER2-VE Advanced/Metastatic Breast Cancer Patients in the PALOMA-2 Study
|
Harbeck, Nadia
|
|
2017
|
36 |
S1 |
p. S43-
1 p.
|
artikel
|
| 82 |
Impact of Molecular Subtypes in Patients with Metastatic Breast Cancer at Diagnosis
|
Madureira, Tânia
|
|
2017
|
36 |
S1 |
p. S62-
1 p.
|
artikel
|
| 83 |
Impact of Next-Generation Sequencing (NGS) for Primary Endocrine Resistance on Breast Cancer Patients
|
Song, Zhenchuan
|
|
2017
|
36 |
S1 |
p. S62-
1 p.
|
artikel
|
| 84 |
Impact of Support Group Intervention on the Quality of Life of Patients with Advanced Breast Cancer
|
Okwor, Vitalis
|
|
2017
|
36 |
S1 |
p. S67-
1 p.
|
artikel
|
| 85 |
Inflammatory Advanced Breast Cancer. The Role of Different Radiation Techniques
|
Offersen, Birgitte Vrou
|
|
2017
|
36 |
S1 |
p. S25-S26
2 p.
|
artikel
|
| 86 |
Inflammatory Breast Cancer: A Single Center Experience from Developing Country
|
Khullar, Pooja
|
|
2017
|
36 |
S1 |
p. S75-
1 p.
|
artikel
|
| 87 |
Influence of Lipophilic Components of Matcha-Tea Extract on PPARγ Dependent Cell Proliferation
|
Schröder, Lennard
|
|
2017
|
36 |
S1 |
p. S41-S42
2 p.
|
artikel
|
| 88 |
Insurance Policies and Professional Career after an Advanced Breast Cancer Diagnosis
|
Nordström, Elizabeth Bergsten
|
|
2017
|
36 |
S1 |
p. S20-
1 p.
|
artikel
|
| 89 |
Introduction of Menthol 1% Cream as the Election Treatment in Patients Suffering from Taxane Induced Neuropathy
|
Garcia, Anabelen Rodriguez
|
|
2017
|
36 |
S1 |
p. S32-
1 p.
|
artikel
|
| 90 |
Is Family Planning (Fertility, Adoption) out of the Question?
|
Paluch-Shimon, Shani
|
|
2017
|
36 |
S1 |
p. S19-S20
2 p.
|
artikel
|
| 91 |
Leaving a Legacy: Half Day Retreat for Young Women Living with Metastatic Breast Cancer
|
Ajango, Mary
|
|
2017
|
36 |
S1 |
p. S67-
1 p.
|
artikel
|
| 92 |
Leptomeningeal Metastases from Breast Cancer: Are We Overtreatening? Decision Algorithms and Assuring Breast Care
|
Matos, Ana Leonor
|
|
2017
|
36 |
S1 |
p. S55-
1 p.
|
artikel
|
| 93 |
Locally Advanced Breast Cancer in Indonesia: Prognostic and Result of Treatment
|
Harahap, Wirsma Arif
|
|
2017
|
36 |
S1 |
p. S65-
1 p.
|
artikel
|
| 94 |
Locally Advanced Breast Cancer in Women under 40 Years-Old: Single Center Study
|
Rêgo, Inês Brandão
|
|
2017
|
36 |
S1 |
p. S60-S61
2 p.
|
artikel
|
| 95 |
Luminal Metastatic Breast Cancer: Best Sequence of Available Therapies
|
Harbeck, Nadia
|
|
2017
|
36 |
S1 |
p. S22-
1 p.
|
artikel
|
| 96 |
Maintenance Therapy (Chemotherapy, Endocrine Therapy, Biologics)
|
Francis, Prudence A.
|
|
2017
|
36 |
S1 |
p. S23-S24
2 p.
|
artikel
|
| 97 |
Management Issues: How and Until When to Treat?
|
Thomssen, Christoph
|
|
2017
|
36 |
S1 |
p. S19-
1 p.
|
artikel
|
| 98 |
Mechanisms of Resistance to Endocrine and Biological Agents
|
Johnston, Stephen R.D.
|
|
2017
|
36 |
S1 |
p. S23-
1 p.
|
artikel
|
| 99 |
Mesenchymal Circulating Tumour Cell Analysis to Predict Efficacy of Eribulin for Metastatic Breast Cancer Patients
|
Horimoto, Yoshiya
|
|
2017
|
36 |
S1 |
p. S40-S41
2 p.
|
artikel
|
| 100 |
Metastatic Breast Cancer Patients Who Achieved Clinical Complete Response after Multidisciplinary Therapy: Clinical Features from a Single Institution
|
Takuwa, Haruko
|
|
2017
|
36 |
S1 |
p. S63-
1 p.
|
artikel
|
| 101 |
Metastatic Breast Cancer Subtype and Clinical Manifestations: Montenegrin Experience
|
Durutovic, Ivana
|
|
2017
|
36 |
S1 |
p. S59-
1 p.
|
artikel
|
| 102 |
Metronomic Chemotherapy: A Good Old Friend
|
El Saghir, Nagi S.
|
|
2017
|
36 |
S1 |
p. S23-
1 p.
|
artikel
|
| 103 |
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 Study
|
Cazzaniga, Marina Elena
|
|
2017
|
36 |
S1 |
p. S48-S49
2 p.
|
artikel
|
| 104 |
Multigene Testing: Aid or Clinical Nightmare
|
André, Fabrice
|
|
2017
|
36 |
S1 |
p. S26-
1 p.
|
artikel
|
| 105 |
Multiple Drug Resistance in Breast Cancer Cells: Mirnaome Dysregulation can Facilitate Expression of Genes Encoding the ATP Binding Cassette (ABC) Transporters
|
Halytskiy, Volodymyr
|
|
2017
|
36 |
S1 |
p. S57-
1 p.
|
artikel
|
| 106 |
Musculoskeletal Pain and Health-Related Quality of Life among Breast Cancer Patients: Evidence from South India
|
Sha, Asmin
|
|
2017
|
36 |
S1 |
p. S69-
1 p.
|
artikel
|
| 107 |
NAB-Paclitaxel (NAB-P) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): Focus on Luminal Cancers. Results from GIM13-AMBRA Study
|
Cazzaniga, Marina Elena
|
|
2017
|
36 |
S1 |
p. S51-S52
2 p.
|
artikel
|
| 108 |
No Lump Required: A Patient Driven Inflammatory Breast Cancer Reserach Initiative Using the Peer Platform
|
Mason, Ginny
|
|
2017
|
36 |
S1 |
p. S39-
1 p.
|
artikel
|
| 109 |
Optimal Sequence with and without Therapies for ABC
|
Krop, Ian E.
|
|
2017
|
36 |
S1 |
p. S20-
1 p.
|
artikel
|
| 110 |
Optimizing Anti-Her-2 Therapies for ABC Potential Role of Immunotherapy
|
Cortés, Javier
|
|
2017
|
36 |
S1 |
p. S21-
1 p.
|
artikel
|
| 111 |
Oral Drugs: Challenges for the Oncology Nurse
|
Boers-Doets, C.B.
|
|
2017
|
36 |
S1 |
p. S24-
1 p.
|
artikel
|
| 112 |
Overall Survival and Patient-Reported Impairment by Fatigue, Pain and Treatment Time in Patients with Advanced Breast Cancer in Routine Practice: Results from the Prospective German TMK Cohort Study
|
Marschner, Norbert
|
|
2017
|
36 |
S1 |
p. S45-
1 p.
|
artikel
|
| 113 |
#Pacientesnocontrole (Patients in Control): Campaign to Increase Access to Metastatic Breast Cancer (MBC) Treatment in Brazil
|
Caleffi, Maira
|
|
2017
|
36 |
S1 |
p. S31-S32
2 p.
|
artikel
|
| 114 |
Palliative Care in Egypt: Challenges and Opportunities
|
Hablas, Mohamed
|
|
2017
|
36 |
S1 |
p. S68-S69
2 p.
|
artikel
|
| 115 |
Patient Navigation: Mitigating the Surge of Advanced Breast Cancer in Sub-Saharan Africa
|
Chikeruba, Runcie
|
|
2017
|
36 |
S1 |
p. S34-
1 p.
|
artikel
|
| 116 |
Patterns of Response to Therapy in ER/PR Positive Metastatic Breast Cancer
|
Sundquist, Marie
|
|
2017
|
36 |
S1 |
p. S56-
1 p.
|
artikel
|
| 117 |
Peritoneal Carcinomatosis and Ascites: Best Practices
|
Diéras, Véronique
|
|
2017
|
36 |
S1 |
p. S27-
1 p.
|
artikel
|
| 118 |
Poster Session
|
|
|
2017
|
36 |
S1 |
p. S17-S18
2 p.
|
artikel
|
| 119 |
Precision/Personalized Medicine: Hopes and Hypes
|
Sledge, George W.
|
|
2017
|
36 |
S1 |
p. S26-
1 p.
|
artikel
|
| 120 |
Predictive Factors for Persistent Pain in Patients with Advanced Breast Cancer Receiving Adjuvant Therapy
|
Alexa-Stratulat, Teodora
|
|
2017
|
36 |
S1 |
p. S70-
1 p.
|
artikel
|
| 121 |
Preference of Treatment Decision-Making in Women with Advanced Breast Cancer
|
Shimizu, Chikako
|
|
2017
|
36 |
S1 |
p. S73-
1 p.
|
artikel
|
| 122 |
Preliminary Data from a Prospective Non-interventional Study to Characterize Real-World Treatment Patterns and Outcomes of Women with ER+/HER2-Advanced/Metastatic Breast Cancer
|
Harbeck, Nadia
|
|
2017
|
36 |
S1 |
p. S48-
1 p.
|
artikel
|
| 123 |
Presentation and Specific Risk Factors of Inflammatory Breast Cancer (IBC): A Multicenter Tunisian Study
|
Turki, Nesrine Mejri
|
|
2017
|
36 |
S1 |
p. S72-S73
2 p.
|
artikel
|
| 124 |
Prevention and Management of Cancer Treatment Induced Neurotoxicity
|
Aapro, Matti S.
|
|
2017
|
36 |
S1 |
p. S26-S27
2 p.
|
artikel
|
| 125 |
Prognostic Factors in Metastatic Breast Cancer Patients to Brain: Retrospective Analysis
|
Gaballah, Ahmed
|
|
2017
|
36 |
S1 |
p. S51-
1 p.
|
artikel
|
| 126 |
Programme
|
|
|
2017
|
36 |
S1 |
p. S9-S12
4 p.
|
artikel
|
| 127 |
Public Hearings and Debate Cycles for Parliamentarians on Breast Cancer
|
Caleffi, Maira
|
|
2017
|
36 |
S1 |
p. S32-S33
2 p.
|
artikel
|
| 128 |
Quality of Life and Psychosocial Need of Metastatic Breast Cancer Patients
|
Mehmood, Tahir
|
|
2017
|
36 |
S1 |
p. S68-
1 p.
|
artikel
|
| 129 |
Randomized Prospective Study: Paclitaxel Every-3-Weekly Paclitaxel and versus Weekly Vinorelbine in Metastatic Breast Cancer
|
Katselashvili, Lika
|
|
2017
|
36 |
S1 |
p. S49-
1 p.
|
artikel
|
| 130 |
Real World Prescription Patterns in Metastatic HR+ Breast Cancer. Analysis from Instituto Nacional de Cancerologia, Mexico City
|
Salinas, Claudia Arce
|
|
2017
|
36 |
S1 |
p. S49-S50
2 p.
|
artikel
|
| 131 |
Regulation of Stemness Properties by Ganoderma Lucidum Extract in Inflammatory Breast Cancer Cells via STAT3 Regulation
|
Martinez-Montemayor, Michelle
|
|
2017
|
36 |
S1 |
p. S41-
1 p.
|
artikel
|
| 132 |
Relapse and Metastatic Spread Patterns in Patients with HER2/neu Positive Breast Cancer who Underwent Targeted Therapy
|
Arkania, Ekaterine
|
|
2017
|
36 |
S1 |
p. S54-S55
2 p.
|
artikel
|
| 133 |
Retrospective Analysis of Advanced Luminal Breast Cancer Patients Treated with Endocrine Therapy (ET) and Palbociclib Within a Compassionate Use Programme
|
Maurer, Christian
|
|
2017
|
36 |
S1 |
p. S48-
1 p.
|
artikel
|
| 134 |
Ribociclib and Endocrine Therapy (ET) in Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER-2) Breast Cancer: The Monaleesa Clinical Trials Program
|
Campone, Mario
|
|
2017
|
36 |
S1 |
p. S50-
1 p.
|
artikel
|
| 135 |
Rise of Metastatic Breast Cancer Incidence in Lebanon: Effect of Refugees and Displaced People from Syria, and Patients from War-Torn Iraq
|
El Saghir, Nagi S.
|
|
2017
|
36 |
S1 |
p. S74-
1 p.
|
artikel
|
| 136 |
Share Decision Making for Better Patient Participation in Advanced Breast Cancer Care
|
Schrieks, Marga
|
|
2017
|
36 |
S1 |
p. S37-
1 p.
|
artikel
|
| 137 |
Shortage of Drugs: Solutions
|
Eniu, Alexandru
|
|
2017
|
36 |
S1 |
p. S28-S29
2 p.
|
artikel
|
| 138 |
Silent Voices Speak: An Advocate’s Journey
|
Mayer, Musa
|
|
2017
|
36 |
S1 |
p. S19-
1 p.
|
artikel
|
| 139 |
Social Media Storytelling as an Advocacy and Support Tool for People Living with Metastatic Breast Cancer
|
Guglielmino, Janine
|
|
2017
|
36 |
S1 |
p. S35-S36
2 p.
|
artikel
|
| 140 |
Sponsored Satellite Symposia
|
|
|
2017
|
36 |
S1 |
p. S13-S14
2 p.
|
artikel
|
| 141 |
Sponsors
|
|
|
2017
|
36 |
S1 |
p. S5-
1 p.
|
artikel
|
| 142 |
Systemic Treatment of Metastatic Breast Cancer (MBC) in Older Adults
|
Biganzoli, Laura
|
|
2017
|
36 |
S1 |
p. S24-
1 p.
|
artikel
|
| 143 |
Tanto POR Hacer
|
Puente, Eliza
|
|
2017
|
36 |
S1 |
p. S35-
1 p.
|
artikel
|
| 144 |
The Behaviour of the Triple Negative Breast Cancer among African Women in Sudan
|
Siddig, Shaimaa
|
|
2017
|
36 |
S1 |
p. S58-S59
2 p.
|
artikel
|
| 145 |
The Biology of Inflammatory Breast Cancer
|
Penault-Llorca, Frédérique
|
|
2017
|
36 |
S1 |
p. S24-S25
2 p.
|
artikel
|
| 146 |
The Identification of the Genes Concerning to the Distant Metastasis of TNBC: The Interaction with AR as an Index
|
Miwa, Noriko
|
|
2017
|
36 |
S1 |
p. S42-
1 p.
|
artikel
|
| 147 |
The Information and Support Needs of Women with Metastatic Breast Cancer who have Dependant Aged Children: A Study to Inform Service Development to Support Women Talk with and Prepare their Children
|
Leadbeater, Maria
|
|
2017
|
36 |
S1 |
p. S68-
1 p.
|
artikel
|
| 148 |
The New Management of Luminal ABC: Management of New Side Effects
|
Barrios, Carlos H.
|
|
2017
|
36 |
S1 |
p. S22-
1 p.
|
artikel
|
| 149 |
The Role of Immunotherapy in the Treatment of Triple Negative Breast Cancer (TNBC)
|
Rugo, Hope S.
|
|
2017
|
36 |
S1 |
p. S29-S30
2 p.
|
artikel
|
| 150 |
The Unmet Information, Supportand Financial Needs of Women with Metastatic Breast Cancer in Australia: Results of Two Breast Cancer Network Australia Studies
|
Spence, Danielle
|
|
2017
|
36 |
S1 |
p. S34-S35
2 p.
|
artikel
|
| 151 |
The World is Not Enough: The Twilight of MBC Patients’ Needs
|
Azmi, Rania
|
|
2017
|
36 |
S1 |
p. S39-S40
2 p.
|
artikel
|
| 152 |
Treating Triple Negative ABC
|
Carey, Lisa A.
|
|
2017
|
36 |
S1 |
p. S30-S31
2 p.
|
artikel
|
| 153 |
Treatment of Advanced Breast Cancer with T-DM1 in a Cancer Center
|
Pereira, Filipa Ferreira
|
|
2017
|
36 |
S1 |
p. S55-S56
2 p.
|
artikel
|
| 154 |
Triplet Combination of Endocrine Therapy with CDK 4/6 Inhibitor, Ribociclib, and MTOR Inhibitor, Everolimus in HR+, HER2-ABC: Results from the Dose-Expansion Cohort
|
Bardia, Aditya
|
|
2017
|
36 |
S1 |
p. S46-S47
2 p.
|
artikel
|
| 155 |
Utilization of Integrative Supportive Services in a Specialized Advanced Breast Cancer Center
|
Pluard, Timothy J.
|
|
2017
|
36 |
S1 |
p. S69-S70
2 p.
|
artikel
|
| 156 |
Welcome
|
Cardoso, Fatima
|
|
2017
|
36 |
S1 |
p. S1-
1 p.
|
artikel
|
| 157 |
What’s New in Biology
|
Prat, Aleix
|
|
2017
|
36 |
S1 |
p. S29-
1 p.
|
artikel
|
| 158 |
Will Biosimilars Become Standard?
|
Koppikar, Smruti
|
|
2017
|
36 |
S1 |
p. S21-S22
2 p.
|
artikel
|
Tijdschrift beschrijving